:

PUBLIC INVESTORS MISSED AI BOOM, SAYS BAILLIE GIFFORD

AI DESK1 MIN READ
MON, APR 13, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Despite anticipated IPOs from SpaceX, Anthropic, and OpenAI, public market investors have already missed significant AI growth, according to Peter Singlehurst, head of private companies at Baillie Gifford.

The high-valuation companies poised to go public in coming months represent later-stage investments after substantial value creation has already occurred in private markets. Singlehurst's comments highlight a persistent gap between private and public market participation in transformative technology sectors. Early-stage AI companies have generated outsized returns for private investors and venture capital firms before reaching public markets. The upcoming IPOs from OpenAI, Anthropic, and SpaceX signal growing investor appetite for exposure to AI and space technology. However, these companies will enter public markets at valuations reflecting years of private funding rounds and operational milestones. This dynamic reflects broader market trends where institutional and individual public investors increasingly access growth opportunities after private markets have already captured early gains. The timing of public debuts often aligns with maturation rather than inception of major technology waves.

■ SOURCES

Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

YESTERDAYAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

YESTERDAYAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

YESTERDAYAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.